• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Glenmark Pharmaceuticals Limited — Updates, 31-07-2026: Press Release

    31-07-2026 | 07:12 pm

    Glenmark Pharma's Q1 FY27 revenue grew 23.1% YoY to ₹4,018.5 Cr, with EBITDA up 38.6% to ₹804.8 Cr and PAT at ₹482.8 Cr. Growth was broad-based, driven by India and North America. The company launched 9 products in the US and initiated direct RYALTRIS® commercialization.

    No comments yet. Be the first to comment!

    All announcements from Glenmark Pharmaceuticals Limited